Rapid approval process broken, says congressman
Patient Safety Monitor Alert, June 2, 2005
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
The Food and Drug Administration's new rapid approval process for new drugs may harm patients because of a lack of oversight, according to a Reuters report.
Congressman Ed Markey (D-MA) said the drug companies are not completing required follow-up studies and the FDA is not double-checking to see that work is done. The result is a lax system which may allow unsafe drugs onto the market, Markey said.
Officials at the FDA said the process is instrumental in getting helpful drugs on the market. Pharmaceutical companies point to the low rate of recall on drugs as proof that the system is safe.
To read the complete article, click here.
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Topic: CMS, OESS post new security compliance review information, checklist
- Catch up on what's new with injections and infusions
- What does case-mix index mean to you?
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- HIPAA Q&A: Answering service messages
- OB services: Coding inside and outside of the package
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- New conflicts of interest create new challenges
- Q&A: Coding 'aspiration without pneumonia'
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched
